NIT
MED icon

NumerixS Investment Technologies’s Medifast MED Stock Holding History

NumerixS Investment Technologies’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-951
Closed -$59K – 1205
2020
Q1 		$59K Buy
951
+47
+5% +$4.28K 0.03% 576
2019
Q4 		$99K Sell
904
-1,196
-57% -$116K 0.02% 678
2019
Q3 		$218K Buy
2,100
+400
+24% +$43K 0.06% 361
2019
Q2 		$218K Sell
1,700
-6,700
-80% -$931K 0.06% 390
2019
Q1 		$1.07M Buy
8,400
+5,900
+236% +$748K 0.14% 169
2018
Q4 		$310K Sell
2,500
-2,600
-51% -$445K 0.1% 222
2018
Q3 		$1.12M Buy
+5,100
New +$1.03M 0.21% 135
2018
Q2 		– Sell
-400
Closed -$37K – 1266
2018
Q1 		$37K Buy
400
+300
+300% +$22.4K 0.01% 867
2017
Q4 		$7K Buy
+100
New +$6.63K ﹤0.01% 1069

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

NumerixS Investment Technologies's MED Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Medifast (MED) in Q2 2020, closing a stake of 951 shares — an estimated $59K sold.

NumerixS Investment Technologies first reported a position in MED in Q4 2017 and held it in 9 quarters. The position peaked at $1.12M in Q3 2018. 224 funds tracked by Wall St. Rank hold MED as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Medifast position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 951 Medifast shares in Q2 2020, an estimated $59K.
  • NumerixS Investment Technologies first reported a position in Medifast in Q4 2017 and held it in 9 quarters.
  • NumerixS Investment Technologies's Medifast position peaked at $1.12M in Q3 2018.
  • 224 funds tracked by Wall St. Rank held Medifast as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.